Acetylator phenotype and congenital malformations.
The hypothesis has been tested that an unusual maternal acetylator phenotype can predispose to congenital malformations in the fetus. The acetylator phenotype of normal caucasian control women and of mothers of malformed children was established by measuring urinary sulphadimidine and its acetylated metabolite. A further control group was the fathers of the malformed newborn. The malformations studied were facial-cleft, spina-bifida and congenital heart disease. The acetylator phenotype was shown not be modified by pregnancy. 49 of 100 (49%) control women were rapid acetylators. Amongst the 108 mothers of malformed babies, 56 (52.8%) were slow acetylators and 52 (47.2%) were fast acetylators, 42 out of 83 (50.5%) of the fathers of malformed were slow acetylators and 41 (49.5%) were fast acetylators. Thus, the acetylator phenotype of the mothers of malformed children is no different from the acetylator phenotype of controls.
Stoll
C
C
Institut de Puericulture, CHU, Strasbourg, France.
Roth
M P
MP
Dott
B
B
Doumit
N
N
Alembik
Y
Y
Welsch
M
M
Imbs
J L
JL
D000015:Abnormalities, Multiple / Q000235:genetics* / Q000378:metabolism; D000107:Acetylation; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011247:Pregnancy; D013418:Sulfamethazine / Q000652:urine
D013418:Sulfamethazine